Or Yat Sun
- SEC CIK
- 0001571212
In the past year, 1 open-market sale filing worth $34.0K and no purchases.
Current role at each company
- ENTA Enanta Pharmaceuticals IncChief Scientific Officeras of Feb 13, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $34.0K
- 1 filing
- Net
- −$34.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Or Yat Sun as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 (view filing) | Dec 5 | Same day | Or Yat SunChief Scientific Officer | SSale | −2.39K | $14.23 | −$34.0K | −0.6%371.4K after | |
| Dec 10, 2024 (view filing) | Dec 6 | 4 days | Or Yat SunChief Scientific Officer | SSale | −2.59K | $8.06 | −$20.9K | −0.7%369.1K after | 10b5-1 |
| Dec 6, 2023 (view filing) | Dec 5 | 1 day | Or Yat SunSr. VP, R&D & CSO | SSale | −2.41K | $9.63 | −$23.2K | −0.6%370.7K after | |
| Mar 17, 2023 (view filing) | Mar 15 | 2 days | Or Yat SunSr. VP & CSO | SSale | −13.9K | $44.45 | −$619.0K | −3.6%374.7K after | 2 lots |